149 related articles for article (PubMed ID: 3525045)
1. Gastric protection by meciadanol. A new synthetic flavonoid inhibiting histidine decarboxylase.
Konturek SJ; Kitler ME; Brzozowski T; Radecki T
Dig Dis Sci; 1986 Aug; 31(8):847-52. PubMed ID: 3525045
[TBL] [Abstract][Full Text] [Related]
2. Effect of meciadanol on gastric secretion and aspirin-induced gastric mucosal injury in humans.
Konturek SJ; Kitler ME; Kwiecien N; Obtulowicz W; Oleksy J; Kopp B
Scand J Gastroenterol; 1984 Nov; 19(8):1099-103. PubMed ID: 6442798
[TBL] [Abstract][Full Text] [Related]
3. Histidine decarboxylase inhibition by O-methyl-3(+)catechin and gastric acid secretion in the cat.
Albinus M; Frisch G; Hennings G
Agents Actions; 1983 Apr; 13(2-3):249-51. PubMed ID: 6869127
[TBL] [Abstract][Full Text] [Related]
4. Histidine decarboxylase inhibition: a novel approach towards the development of an effective and safe gastric anti-ulcer drug.
Parmar NS; Hennings G; Gulati OP
Agents Actions; 1984 Dec; 15(5-6):494-9. PubMed ID: 6397982
[TBL] [Abstract][Full Text] [Related]
5. Gastric anti-ulcer activity of (+)-cyanidanol-3, a histidine decarboxylase inhibitor.
Parmar NS; Ghosh MN
Eur J Pharmacol; 1981 Jan; 69(1):25-32. PubMed ID: 7202511
[TBL] [Abstract][Full Text] [Related]
6. The protective effect of Meciadanol (O-methyl-3(+)-catechin) on experimental ulceration.
Jayaraj AP; Lewin MR; Tovey FI; Kitler ME; Clark CG
Eur J Pharmacol; 1988 Mar; 147(2):265-71. PubMed ID: 3366177
[TBL] [Abstract][Full Text] [Related]
7. Histamine and acute haemorrhagic lesions in rat gastric mucosa: prevention of stress ulcer formation by (+)-catechin, an inhibitor of specific histidine decarboxylase in vitro.
Reimann HJ; Lorenz W; Fischer M; Frölich R; Meyer HJ; Schmal A
Agents Actions; 1977 Mar; 7(1):69-73. PubMed ID: 871094
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gastric and intestinal antisecretory and protective effects of prostacyclin and its stable thia-imino-analogue (Hoe 892) in conscious rats.
Konturek SJ; Brzozowski T; Radecki T; Pastucki I
Prostaglandins; 1984 Oct; 28(4):443-53. PubMed ID: 6395196
[TBL] [Abstract][Full Text] [Related]
9. The gastric anti-ulcer activity of naringenin, a specific histidine decarboxylase inhibitor.
Parmar NS
Int J Tissue React; 1983; 5(4):415-20. PubMed ID: 6671888
[TBL] [Abstract][Full Text] [Related]
10. The gastric antisecretory activity of 3-methoxy-5,7,3'4'-tetrahydroxyflavan (ME)--a specific histidine decarboxylase inhibitor in rats.
Parmar NS; Hennings G
Agents Actions; 1984 Oct; 15(3-4):143-5. PubMed ID: 6524513
[TBL] [Abstract][Full Text] [Related]
11. SU-840, a novel synthetic flavonoid derivative of sophoradin, with potent gastroprotective and ulcer healing activity.
Brzozowski T; Konturek SJ; Kwiecien S; Pajdo R; Drozdowicz D; Sliwowski Z; Muramatsu M
J Physiol Pharmacol; 1998 Mar; 49(1):83-98. PubMed ID: 9594413
[TBL] [Abstract][Full Text] [Related]
12. Distinction between antiulcer effect and cytoprotection.
Robert A; Lancaster C; Davis JP; Field SO; Nezamis JE
Scand J Gastroenterol Suppl; 1984; 101():69-73. PubMed ID: 6599540
[TBL] [Abstract][Full Text] [Related]
13. Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa.
Fukuda T; Arakawa T; Shimizu Y; Ohtani K; Higuchi K; Kobayashi K
J Clin Gastroenterol; 1995; 20 Suppl 2():S5-7. PubMed ID: 7594340
[TBL] [Abstract][Full Text] [Related]
14. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats.
Onoda Y; Takido M; Magaribuchi T; Tamaki H
Jpn J Pharmacol; 1990 Apr; 52(4):631-8. PubMed ID: 2342230
[TBL] [Abstract][Full Text] [Related]
15. Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Drozdowicz D; Kwiecieñ S; Pajdo R; Bielanski W; Hahn EG
Eur J Pharmacol; 2000 Jun; 398(1):147-58. PubMed ID: 10856459
[TBL] [Abstract][Full Text] [Related]
16. Nocloprost, a unique prostaglandin E2 analog with local gastroprotective and ulcer-healing activity.
Konturek SJ; Brzozowski T; Drozdowicz D; Krzyzek E; Garlicki J; Majka J; Dembinski A; Stachura J; Amon I
Eur J Pharmacol; 1991 Apr; 195(3):347-57. PubMed ID: 1868881
[TBL] [Abstract][Full Text] [Related]
17. alpha-Fluoromethyl histidine. Inhibition of histidine decarboxylase in pylorus ligated rat.
Bouclier M; Jung MJ; Gerhart F
Biochem Pharmacol; 1983 May; 32(10):1553-6. PubMed ID: 6860344
[TBL] [Abstract][Full Text] [Related]
18. Ulcer formation and cytoprotection by acetazolamide.
Robert A; Lancaster C; Davis JP; Kolbasa KP; Nezamis JE
Eur J Pharmacol; 1985 Dec; 118(3):193-201. PubMed ID: 3866690
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of histidine decarboxylase decrease basal gastric acid secretion in the rat.
Westerberg VS; Geiger JD
Pharmacol Biochem Behav; 1987 Nov; 28(3):419-22. PubMed ID: 3685079
[TBL] [Abstract][Full Text] [Related]
20. [Effects of elcatonin, a synthetic analogue of eel calcitonin, on acute gastric and duodenal lesions and gastroduodenal function in rats].
Takeuchi K; Furukawa O; Tanaka H; Nishiwaki H; Okabe S
Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):123-33. PubMed ID: 3699626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
